C4 Therapeutics, Inc.CCCCNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 46 | 31 | 21 |
| Gross Profit | 46 | 31 | 13 |
| Operating Income | -82 | -130 | -139 |
| Net Income | -84 | -128 | -132 |
| EBITDA | -80 | -124 | -122 |
| EPS Diluted | -1.82 | -2.62 | -2.67 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 76 | 30 | 127 |
| Total Current Assets | 326 | 288 | 271 |
| Total Assets | 507 | 431 | 376 |
| Total Current Liabilities | 51 | 45 | 43 |
| Total Liabilities | 117 | 142 | 130 |
| Total Equity | 390 | 289 | 246 |
| Total Debt | 43 | 87 | 71 |
| Net Debt | -33 | 57 | -56 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -87 | -106 | -107 |
| Capital Expenditure | -1 | -5 | -2 |
| Free Cash Flow | -88 | -111 | -109 |
| Stock-Based Comp | 22 | 30 | 27 |
| Net Change in Cash | -105 | -46 | 97 |